Targeted delivery to CD44 receptor through functionalized nanomedicines- Prof. Elias FATTAL, dell’Institut Galien – Université Paris-Saclay


Elias Fattal is a full professor in Drug Delivery Science at the University of Paris-Saclay in Châtenay-Malabry, France, and has been President of APGI from 2003 to 2010. He has been the head of the Institut Galien Paris-Saclay (2010-2019). Over the past 25 years, he has made fundamental and applied contributions to the fields of drug delivery using nanotechnologies for targeted or local delivery of drugs and nucleic acids. He has been recently focusing on lung nanotoxicity as well as on the design of nanoparticle-based delivery systems for the delivery of anti-inflammatory drugs and nucleic acids. Several of his patents have been licensed to the pharmaceutical industry. He has contributed to around 300 publications and book chapters. Prof. Fattal has received the Pharmaceutical Sciences World Congress (PSWC) Research Achievement (2007), the Controlled Release Society fellow award (2016), was awarded in 2016 by the French Academy of Sciences for his research at the interface of chemistry and biology and more recently in 2018 received the Maurice-Marie Janot Award. He serves on the editorial board of several scientific journals and is a member of the National Academy of Pharmacy, the National Academy of Medicine, and the European Academy of Sciences.

21/02/2023

21 Febbraio 2023

Aula B-  Plesso Tecce

dalle ore 11.00- alle 12.00

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma